Growing community of inventors

Seoul, South Korea

Jae Ryoung Hwang

Average Co-Inventor Count = 1.82

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 6

Jae Ryoung HwangYoung Woo Park (1 patent)Jae Ryoung HwangJung Jae Yu (1 patent)Jae Ryoung HwangJi Hyun Park (1 patent)Jae Ryoung HwangMyeoung Hee Jang (1 patent)Jae Ryoung HwangMi-ju Park (1 patent)Jae Ryoung HwangJe-Ho Lee (1 patent)Jae Ryoung HwangSo-Young Choi (1 patent)Jae Ryoung HwangSungsub Kim (1 patent)Jae Ryoung HwangEun-Jung Song (1 patent)Jae Ryoung HwangMi-Ju Park (0 patent)Jae Ryoung HwangJae Ryoung Hwang (2 patents)Young Woo ParkYoung Woo Park (40 patents)Jung Jae YuJung Jae Yu (17 patents)Ji Hyun ParkJi Hyun Park (16 patents)Myeoung Hee JangMyeoung Hee Jang (7 patents)Mi-ju ParkMi-ju Park (6 patents)Je-Ho LeeJe-Ho Lee (5 patents)So-Young ChoiSo-Young Choi (4 patents)Sungsub KimSungsub Kim (4 patents)Eun-Jung SongEun-Jung Song (3 patents)Mi-Ju ParkMi-Ju Park (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Sungkyunkwan University (2 from 1,245 patents)

2. Korea Research Institute of Bioscience and Biotechnology (1 from 321 patents)


2 patents:

1. 9072707 - Use of C-terminal domain of IGFBP-5 comprising heparin-binding domain as an angiogenesis inhibitor

2. 8197809 - CD9-specific human antibodies

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…